The board of Cyclopharm Limited announced the appointment of Professor Gregory King as a non-executive director, with the appointment effective immediately. Dr. King is a world renowned respiratory physiologist who brings over 25 years' experience as a clinician, educator and researcher to the Cyclopharm board. Dr. King is Professor of Respiratory Medicine at the Northern and Central Clinical Schools of the University of Sydney and a Practitioner.

Greg is also the Staff Specialist in the Department of Respiratory Medicine at Royal North Shore Hospital, where he directs the asthma service and is the Medical Director of the Respiratory Investigation Unit, and the Research Leader of the Airway Physiology and Imaging Group at the Woolcock Institute of Medical Research. In addition, Dr. King supervises PhD and other postgraduate students at the University of Sydney. Dr. King has investigated the mechanics of airways disease in relation to clinical aspects of disease.

His expertise includes complex measurements of airway and lung function, including the use of Cyclopharm's Technegas® in numerous research initiatives since 1997. He has a clinical and research interest in asthma, COPD and bronchiolitis in haemopoietic stem cell transplant recipients. His research is designed to better understand and manage airways diseases, with the ultimate objective of developing cures.

Dr. King is a member of the American Thoracic Society (ATS), Asia Pacific Society of Respirology (APSR), European Respiratory Society (ERS), the American Physiological Society (APS) and Thoracic Society of Australia and New Zealand (TSANZ). He is Chair Elect, Respiratory Structure and Function Assembly, APSR, and maintains active participation in the activities of the TSANZ in terms of teaching, professional development and executive committee function. Professor King was born in New Zealand and is a medical graduate of Otago University in New Zealand.

He completed his PhD at Sydney University on airway closure in asthma and completed Postdoctoral Research Fellowships at Sydney University and at the Pulmonary Research Laboratory of the University of British Columbia in Vancouver.